VaRi Bioscience GmbH
PrivateLast Round
Seed
Dec 5, 2023
Company Overview
VaRi Bioscience GmbH is a biotechnology company that develops innovative pharmaceutical products for women's health, focusing on vaginal ring drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
women's healthvaginal ringdrug deliveryfemtechsustained-releasebiotechnologypharmaceutical developmenthormonal therapylong-acting deliverymedical devicedrug delivery platformclinical-stage biotechcontract manufacturingCMOlicensing agreement
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VaRi Bioscience GmbH Comparables
Compare VaRi Bioscience GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evestra, Inc. | 83% | |
| AnelleO | 81% | |
| LiGalli B.V. | 79% | |
VaRi Bioscience GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2023 |
VaRi Bioscience GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VaRi Bioscience GmbH's valuation, stock price, and market status.
Firmographic Details
HeadquartersGermany
Employee Range9
Year Founded2021
Last FundingDec 5, 2023